Skip to content

Effectiveness of Silver Nitrate Solution in the Treatment of Anal Fistula

Effectiveness of Silver Nitrate Solution in the Treatment of Anal Fistula: A Novel Strategy for Managing Anal Fistula

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01929525
Enrollment
70
Registered
2013-08-28
Start date
2013-08-31
Completion date
2014-03-31
Last updated
2013-08-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anal Fistula

Brief summary

Effectiveness of silver nitrate solution in treatment of anal fistula is is aimed to be investigated.

Detailed description

The anal fistula is a granulation tissue-lined tract, we thought of a way to ablate this granulation tissue using a chemical agent, which would eventually induce healing with fibrosis and closure of the tract without any surgical intervention. Aiming to reduce the surgery related complications; we investigated the effectiveness of silver nitrate solution as a chemical agent in the treatment of anal fistula.

Interventions

None listed

Sponsors

Marmara University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
MALE
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

All patients with the diagnosis of anal fistula Patients with recurrence

Exclusion criteria

Patients who do not sign the informed consent

Design outcomes

Primary

MeasureTime frameDescription
Number of anal fistula patients treated with silver nitrate solution.1 yearThe primary end point in the study was to assess the efficacy of the silver nitrate in the treatment of anal fistula. The number of anal fistula patients who are treated with silver nitrate solution will be calculated. The role of silver nitrate solution in anal fistula treatment will be investigated

Secondary

MeasureTime frameDescription
Therapeutic factors1 yearThe secondary end point was to identify the clinical and therapeutic factors that significantly affect the primary endpoint.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026